Hematology TimesOrphan designation recommended for PCM-075August 4, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMethod may enable eradication of LSCs in AMLAugust 3, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsVadastuximab talirine gives big boost to AML remissionAugust 2, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesInhibitor receives breakthrough designation for AMLAugust 2, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesGlobal burden of hematologic malignanciesJuly 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesStudy could change treatment of MLSM7July 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLMyelodysplastic Syndrome
Hematology TimesTreatments, disease affect spermatogonia in boysJuly 25, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPediatricsTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesFDA approves drug for IDH1-mutated AMLJuly 23, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology NewsFDA approves Nivestym, second biosimilar to NeupogenJuly 20, 2018AMLPatient & Survivor CareLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves IDH1 inhibitor for relapsed/refractory AMLJuly 20, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesDiabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesStudy suggests dasatinib could treat AML, JMMLJuly 18, 2018Leukemia, Myelodysplasia, TransplantationPediatricsAML
Hematology TimesExplaining enasidenib resistance in AMLJuly 17, 2018Leukemia, Myelodysplasia, TransplantationAML
CAR T Therapy: From Bench to Bedside and BackJuly 15, 2018AnemiaLeukemia, Myelodysplasia, TransplantationALLAMLCellular TherapyLymphoma & Plasma Cell DisordersMultiple Myeloma
